Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion
NCT ID: NCT02714231
Last Updated: 2017-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
100 participants
INTERVENTIONAL
2016-03-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy
NCT02714699
Hyoscine Butyl Bromide in Reducing Pain During HSG
NCT02709603
Efficacy of Ketoprofen Before Hysterosalpingography
NCT02905045
Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section
NCT02141321
Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography
NCT04500470
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
diclofenac
oral diclofuhenac sodium
diclofenac sodium (cataflam)
The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure
hyoscine
oral hyoscine butyl bromide
hyoscine butyl bromide (buscopan)
The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
diclofenac sodium (cataflam)
The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure
hyoscine butyl bromide (buscopan)
The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women not taken misoprostol prior to intrauterine device insertion
* Women who will accept to participate in the study
Exclusion Criteria
20 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Abbas
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ahmed abbas, MD
Role: PRINCIPAL_INVESTIGATOR
Woman health hospital Assiut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed Abbas
Assiut, Cairo Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DS-HB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.